News

Contributions to global health include insulin, penicillin, polio vaccine; continues quest for potential new medicinesEli Lilly and Company will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to...

Gilead Sciences Inc announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch Healthcare Conference in Las Vegas. Paul R. Carter, Gilead’s Executive Vice President, Commercial Operations, will provide an overview...

Baxter International Inc. announced that Jill Schaaf, who served as President, Renal, since May 2014, will be leaving the company. Effective May 3, 2016, Giuseppe Accogli, former region head for Baxter’s U.S. Renal business, has assumed the role of...

Alexion Pharmaceuticals, Inc announced that management will present at the Bank of America Merrill Lynch 2016 Health Care Conference in Las Vegas on Tuesday, May 10, 2016 at 10:40 a.m., Pacific Time. An audio webcast of...

AbbVie a global biopharmaceutical company, announced that it will acquire Stemcentrx and its lead late-stage asset rovalpituzumab tesirine (Rova-T) currently in registrational trials for small cell lung cancer (SCLC). Rova-T is a novel biomarker-specific therapy that is derived...

Eli Lilly and Company will attend the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016. David Ricks, Lilly senior vice president and president of Lilly Bio-Medicines, will participate in a fireside chat at 8:00...

AstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic® (lesinurad). Zurampic was approved by the US Food and Drug Administration (FDA) in December 2015, in combination with a...